The management of residual or recurrent central neurocytoma

Abstract

Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative activity demonstrated, the extent of surgical resection, the neuroanatomic location and accessibility of residual tumor, and the patient's postoperative condition. The risks and benefits of additional surgery, radiation therapy, and/or chemotherapy should be weighed and individualized based on these factors and guided by the existing literature.

Keywords: Central neurocytoma neurosurgery; Central neurocytoma radiotherapy; Mixed glial-neuronal tumor; Recurrent central neurocytoma; Residual central neurocytoma.